logo
15:59 Dec 05

Sai Life Science Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
875.90
+8.40 (+0.97%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Sai Life Science Ltd. Financials

Sai Life Science Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
875.90
+8.40 (+0.97%)
15:59 Dec 05
Quality
image/svg+xml

77/100
High Financial Strength

Valuation
image/svg+xml

33/100
Mid Valuation

Technical

50/100
Technically Neutral

Strength

13

Weakness

3

Opportunity

1

Threats

0

7.99 %

ROE %

5.38 %

ROA %

13.62

EPS

102.12

BVPS

10.03 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
869.59 1217.14 1465.18 1694.57 1911.27
Operating Expenses +
748.32 1052.21 1179.69 1288.92 1410.79
Raw Material
269.59 427.18 423.3 460.8 535.66
Increase Decrease in Cost
-2.83 -4.59 22.43 4.97 -1.93
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
308.97 417.29 494.9 549.12 579.39
Miscellaneous Expenses
172.59 212.33 239.06 274.03 297.67
Operating Profit
121.27 164.93 285.49 405.65 500.48
Other Income
28.15 27.97 29.09 36.78 38.57
Depreciation
90.16 99.43 119.44 138.57 145.22
Interest
49.57 77.06 85.91 76.16 67.31
Profit before tax and exceptio..
9.7 16.41 109.23 227.7 326.52
Exceptional Items
0 0 0 0 0
PBT
9.7 16.41 109.23 227.7 326.52
Provision for Taxation
3.47 6.42 26.42 57.57 82.43
Net Profit
6.23 9.99 82.81 170.13 244.09
NET Profit after MI
6.23 9.99 82.81 170.13 244.09
EPS
0.35 0.55 4.57 8.83 12.25
Operating Profit Margin (%)
13.95 13.55 19.49 23.94 26.19
Net Profit Margin (%)
0.72 0.82 5.65 10.04 12.77

Sai Life Science Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Dec 2024 Mar 2025 Jun 2025 Sep 2025
Promoter 34.90 35.20 35.20 35.20
FII 22.50 14.60 12.40 11.70
Public 29.90 21.60 13.20 12.00
Others 12.70 28.60 39.20 41.10
Shareholder Shares Holding %
Research 360 logo
Download Our App On: